Revealed: Matthew Perry’s $55K Ketamine Addiction Shock

Doctor filling syringe with vaccine from vial.

Matthew Perry’s last month on earth exposes a brutal question most people never ask out loud: when does “innovative treatment” quietly turn into drug dealing in a white coat?

Story Snapshot

A licensed physician admitted he illegally supplied ketamine to Perry despite knowing his addiction history and lack of medical supervision ^[1]
Federal agents mapped a small ketamine supply chain: doctor, middleman, and personal assistant delivering vials to Perry ^[2]
The government framed the operation as profit-driven trafficking, not legitimate psychiatric care ^[1]^[2]
The headline claim that Perry paid $55,000 in one month rests on documentary narration, not yet on public financial records

How Matthew Perry Went From Patient To Target Market

Federal prosecutors describe a familiar arc: Matthew Perry began with legal ketamine therapy for severe depression, then slipped into a gray market where the doctor-patient relationship looked more like a cash business.^[1]^[2] One former California clinic owner, Salvador Plasencia, admitted in court that he repeatedly distributed ketamine vials to Perry while knowing two crucial facts: Perry had a widely known addiction history, and an untrained personal assistant—not medical staff—was injecting the drug at home.^[1] That combination would alarm any common-sense parent, let alone a cautious physician.

According to the United States Department of Justice, Plasencia did not merely overprescribe; he pleaded guilty to four counts of distribution of ketamine and later surrendered his medical license.^[1] The Drug Enforcement Administration described a broader network that included a North Hollywood dealer, Jasveen Sangha, and intermediary Erik Fleming, who arranged transfers totaling 51 vials of ketamine to Perry’s circle.^[2] At that point the setup no longer resembled a monitored clinic; it looked like a private pipeline feeding a desperate, wealthy client. Older readers will hear echoes of the opioid-pill-mill era in that description, and the resonance is not accidental.

What The Government Can Prove Versus What The Documentaries Claim

Press releases and documentaries now float the attention-grabbing claim that Perry paid roughly $55,000 in one month for ketamine. That number makes for great television, but the public record so far does not show billing statements, bank records, or forensic accounting that pin it down.^[2]^[3] Prosecutors instead focus on what they can prove beyond a reasonable doubt: unlawful distribution, knowledge of addiction, and unsafe administration. From a rule-of-law standpoint, that distinction matters. Conservatives, in particular, should insist on evidence before assuming every outrageous-sounding dollar figure is accurate.

The government’s narrative does, however, support a narrower but damning picture. Plasencia sold vials directly, offloading responsibility for dosing and monitoring onto a personal assistant with no medical training.^[1] Sangha, the so-called “ketamine queen,” functioned as a drug supplier rather than a treating clinician, and agents later seized cash, a money-counting machine, a scale, and packaging materials in a separate case.^[2] Those concrete details justify calling the operation a trafficking network, even if the precise monthly revenue remains unverified in the public filings.

The Gray Zone Between Treatment And Trafficking

Ketamine itself is not some fringe street chemical. Hospitals use it every day as an anesthetic. Psychiatrists now use low-dose infusions to treat stubborn depression, post-traumatic stress, and chronic pain when other options fail.^[4] For some patients, those carefully supervised infusions restore the will to live and function. That context matters because it undercuts simplistic narratives that “ketamine killed Matthew Perry” in the same way people once said “pain pills killed patients” while ignoring legitimate medical uses. Personal responsibility and medical innovation both deserve respect.

The question here is not whether ketamine can ever be appropriate. It is whether Perry’s later suppliers still operated inside anything recognizable as real medicine. Legitimate ketamine clinics track dosage, monitor blood pressure and breathing, and keep tight inventory controls. They do not send patients home with vials to be injected by friends or assistants. They document every administration in a chart and expect to answer to state medical boards if something goes wrong. When a physician starts selling sealed vials to a known addict and walks away from supervision, that crosses a moral and legal line that most conservatives would recognize immediately.

Exploitation, Personal Choice, And What We Still Do Not Know

Even with guilty pleas and twenty-page press releases, parts of the story remain murky. Public documents do not yet show detailed clinic ledgers, price lists, or text messages setting out “we will milk this guy for fifty-five thousand a month.”^[1]^[2]^[3] Commentators talk about one doctor allegedly calling Perry a “moron” in a message and bragging about the money, but those communications are summarized rather than fully published. Until full plea agreements, sentencing memoranda, and exhibits become accessible, any sweeping claim about exact profits stays partly speculative.

Matthew Perry paid doctors roughly $55,000 in less than a month for ketamine treatments. Investigators later uncovered worrisome text messages.

Watch “Hollywood Demons” Monday on ID and stream on @HBOMax.#HollywoodDemons pic.twitter.com/Wgv0bNbpFQ

— Investigation Discovery (@DiscoveryID) May 16, 2026

Still, the pattern revealed so far should bother anyone who believes in equal justice and limited but real regulation. A wealthy, addicted patient chasing relief became the center of a cottage industry that mixed licensed credentials with street-style distribution. The law stepped in only after a celebrity died. Meanwhile, countless unknown patients move through similar gray zones, minus the news cameras. Ketamine, like guns or prescription opioids, is not inherently evil; it is a tool that demands standards and accountability. When professionals discard both, they should not be surprised when the government—and the public—treat them not as healers, but as traffickers with diplomas.^[1]^[2]^[4]